期刊文献+

多烯康对冠心病患者血管内皮功能的影响

Influence of Duoxikang on the vascular endothelial function in patients with coronary heart disease
下载PDF
导出
摘要 目的研究多烯康对冠心病患者血管内皮功能的影响。方法对36例冠心病患者和30例健康人采用高分辨血管外超声技术测定肱动脉血流介导的舒张功能及硝酸甘油介导的舒张功能,冠心病组服用多烯康12周后检测。结果研究表明冠心病组肱动脉血流介导的舒张及硝酸甘油介导的舒张反应均低于对照组(P<0.01),冠心病组多烯康治疗后较前明显改善(P<0.01)。结论多烯康可改善冠心病患者血管内皮功能。 Objective To evaluate the effect of Duoxikang on vascular endothelial dilation function in patients with coronary heart disease. Methods Thirty-six patients with coronary heart disease and thirty normal subjects were studied, the flow-mediated dilatation and glyceryl trinitrate(GTN)-induced vasodilation of brachial artery were measured by high resolution ultrasound technique. After twelve weeks treatment with Duoxikang, subjects in group of coronary heart disease were remeasured. Results The flow-mediated dilatation and GTN-induced vasodilation of brachial artery in patients with coronary heart disease were significantly reduced as compared with those in control group. These indices in patients with coronary heart disease after treatment with Duoxikang were significantly better than those before the treatment. Conclusion Duoxikang may improve the vascular endothelial dilation function in patients with coronary heart disease.
出处 《中国海洋药物》 CAS CSCD 2006年第1期52-53,共2页 Chinese Journal of Marine Drugs
关键词 冠心痛 血管内皮功能 多烯康 coronary heart disease vascular endothelial function Duoxikang
  • 相关文献

参考文献7

  • 1Celermajer DS, Sorensen KE, Gooch VM, et al.Noninvasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis[J]. Lancet, 1992,340:1111.
  • 2Kugiyama K,Yosue H,Okumura K,et al. Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina[J]. Circulation, 1996,94:266.
  • 3李向平,赵水平,张湘瑜,高梅,周启昌.高密度脂蛋白对血管内皮依赖性舒张功能的影响[J].中华心血管病杂志,2000,28(3):203-206. 被引量:32
  • 4Adams MR, Robinson J, McCredie R, et al. Smooth muscle dysfunction occurs independently of impaired endothelium dependent dilation in adults at risk of atheroclerosis[J]. J Am Coll Cardiol,1998 ,32(1):123.
  • 5Riegger G,Abletshauser C, Ludwig M, et al. The effect of fluvastatin on cardiac events in patients with symptomatic coronary artery disease during one year of treatment [J]. Atherosclerosis,1999,144(1):263 .
  • 6Ballantyne CM, Herd JA, Ferlic LL, et al. Influence of low HDL on progression of coronary artery disease and response to fluvastatin therapy [J]. Circulation, 1999, 99(6) :736.
  • 7Serruys PW, Foley DP,Jackson G, et al. A randomized placebo controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty:final results of the fluvastatln angiographic restenosis(FLARE) trial [J]. Eur Heart J ,1999,20(1):58.

共引文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部